REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

BBraun Pharmaceuticals SA (Romania)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BBraun Pharmaceuticals SA Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

S.C. Helvetica Profarm S.A. was founded in 1997 and became operational in 1999. The main field of activity is the production of solutions for perfusions under the licence of the B.Braun Concern, delivered exclusively by the Romanian company B.Braun Medical S.R.L.
Note:In 2010 the company changed its name, Helvetica Profarm S.A. becoming B.Braun Pharmaceuicals S.A..

Headquarters
Strada Louis Pasteur Nr. 2
TIMISOARA; Timis; Postal Code: 300264

Contact Details: Purchase the BBraun Pharmaceuticals SA report to view the information.

Basic Information
Total Employees:
Purchase the BBraun Pharmaceuticals SA report to view the information.
Outstanding Shares:
Purchase the BBraun Pharmaceuticals SA report to view the information.
Registered Capital:
Purchase the BBraun Pharmaceuticals SA report to view the information.
Financial Auditors:
Purchase the BBraun Pharmaceuticals SA report to view the information.
Incorporation Date:
March 20, 1997
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
99.9997%
Purchase this report to view the information.
0.0003%
Subsidiaries
Banat Park Services SRL
10%
Company Performance
Financial values in the chart are available after BBraun Pharmaceuticals SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
1.72%▲
Total operating revenue
-41.21%▼
Operating profit (EBIT)
N/A
EBITDA
4.55%▲
Net Profit (Loss) for the Period
74.97%▲
Total assets
-30.68%▼
Total equity
-2.36%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
15.5%▲
Return on Equity (ROE)
7.01%▲
Quick Ratio
-0.13%▼
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo